The Zhitong Finance App learned that Ping An Health (01833) continues to innovate and continue to lead the healthcare industry. On January 25, Ping An Health and Zhongyuan Xiehe officially reached a strategic cooperation to jointly explore a new model of cellular health management services. In addition, Ping An Health and Hangzhou Jiuzhou Pharmacy Chain Co., Ltd. recently attended the “One City, One Store” strategic cooperation conference to explore innovative models of multi-dimensional pharmaceutical enterprise cooperation.

In the field of life sciences, cutting-edge technologies such as stem cells and immune cells play an important role in clinical research. Through this strategic cooperation, Ping An Health will complement each other's advantages and share resources with Zhongyuan Xiehe to continuously enhance their respective competitiveness. While bringing business opportunities to both parties, it will also promote technological innovation and market expansion in the life sciences sector.

In the pharmacy retail sector, Ping An Health and Hangzhou Jiuzhou jointly tailor commercial insurance service improvement plans to optimize customer experience. At the same time, Ping An Health will also use strong medical resources to enable customized medication recommendation services for Hangzhou Jiuzhou customers, provide long-term medication tracking services according to medication usage conditions, enhance user experience, and enhance the advantages of regionalized services in Hangzhou and Kyushu. In 2024, Ping An Health will select closely cooperating chain brand pharmacies in a number of key cities to create a new “one city, one store” business format.

Since entering the deepening period of Strategy 2.0, Ping An Health has steadily implemented the “managed medical+family doctor membership+O20 healthcare service” strategic model, using Ping An Family Doctor as a full-link healthcare service, representing payers' integration of “three to three” healthcare resources, including online/store/home, and improving the closed loop of managed care through continuous links and expansion of the medical ecosystem.

As the flagship of Ping An Group's healthcare ecosystem, Ping An Health's F2C business path has not only successfully completed but also become one of the drivers of sustainable growth. In terms of F (financial) channels, Ping An Group's resource support is a major contributor to current revenue. Over 60% of Ping An Health's revenue comes from Ping An Group and its subsidiaries or uses Ping An's agency network. C (individual) channel users mainly switched from the F side and the B side (enterprise). More than 20% of revenue came from enterprise customers. By June 2023, 1,198 enterprise customers had 3.9 million paying users (an increase of 32.4% over 978 companies at the end of 2022).

Safe, healthy and positive industry trends have also been well received by major banks. Research reports published by brokerage firms, including Guojin Securities, gave Ping An Health a rating of buying and increasing its holdings. With the market's correction, Ping An Health Hong Kong stock price is currently seriously undervalued, and the investment value is highlighted.